China Medical & HealthCare Group Limited
COLRFOTCHealthcare
$0.08
+$0.00(+0.00%)
Market Cap$123008776
P/E Ratio—
52W High$0.08
52W Low$0.0001
China Medical & HealthCare Group Limited (COLRF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · COLRF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.63B | $1.57B | $1.44B | $1.48B | $1.21B |
| Cost of Revenue | $1.30B | $1.28B | $1.28B | $1.30B | $1.09B |
| Gross Profit | $0.32B | $0.29B | $0.16B | $0.18B | $0.12B |
| Gross Margin %(computed) | 19.95% | 18.24% | 11.25% | 11.92% | 10.28% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.22B | $0.23B | $0.26B | $0.22B | $0.22B |
| Total Operating Expenses | $0.24B | $0.20B | $0.20B | $0.20B | $0.14B |
| Operating Income | $0.09B | $0.08B | ($0.04B) | ($0.02B) | ($0.01B) |
| Operating Margin %(computed) | 5.29% | 5.30% | -2.73% | -1.43% | -1.07% |
| Interest Income | $0.03B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.05B | $0.06B | $0.06B | $0.05B |
| Income Before Tax | $0.06B | $0.04B | ($0.12B) | ($0.11B) | ($0.10B) |
| Income Tax Expense | $0.02B | $0.01B | $0.00B | $0.02B | $0.01B |
| Net Income | $0.03B | $0.01B | ($0.12B) | ($0.14B) | ($0.11B) |
| Net Margin %(computed) | 1.77% | 0.72% | -8.59% | -9.30% | -9.21% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.03 | $0.01 | $-0.17 | $-0.19 | $-0.15 |
| Wtd Avg Shares | 1.09B | 0.92B | 0.73B | 0.73B | 0.73B |
| EBITDA | $0.18B | $0.17B | $0.05B | $0.05B | $0.07B |
| EBITDA Margin %(computed) | 11.27% | 11.14% | 3.23% | 3.54% | 5.75% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · HKD · B
Explore more China Medical & HealthCare Group Limited data
About China Medical & HealthCare Group Limited (COLRF) Income Statement
China Medical & HealthCare Group Limited (COLRF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2024, COLRF reported revenue of $1.63B, gross profit of $0.32B (gross margin 19.95%), and net income of $0.03B — a net profit margin of 1.77%.
Frequently asked questions
COLRF · 4 questionsChina Medical & HealthCare Group Limited (COLRF) reported revenue of $1.63B for 2024, up 3.7% year-over-year.
COLRF revenueCOLRF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09